INVESTIGATOR-INITIATED PHASE II STUDY OF PEMBROLIZUMAB IMMUNOLOGICAL RESPONSE EVALUATION (INSPIRE)

Registry ID

INSPIRE-001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY HEALTH NETWORK

Start date

2021-12-10

Last update

2015-12-11

Conditions

• UNSPECIFIED

Related clinical trials

• CONTINUING TREATMENT FOR SUBJECTS WHO HAVE PARTICIPATED IN A PRIOR PROTOCOL INVESTIGATING ELOTUZUMAB (CONTINUATION PHASE 2 ROLL-OVER PROTOCOL)
• AN OBSERVATIONAL, OPEN-LABEL, NON-RANDOMIZED STUDY TO MONTIOR FOR ADVERSE DRUG REACTIONS AMONG PATIENTS ADMINISTERED FEDORAK-MANUFACTURED [F-18]-FDG INJECTION
• EXPLORING THE EFFECTS OF PRAZOSIN ON BASAL DOPAMINE IN HEALTHY HUMANS: A [11C]-(+)-PHNO PET STUDY
• COMPARISON OF MAO-A VT BETWEEN HEALTHY MEN AND WOMEN MEASURED WITH [11C]-HARMINE PET

View on source registry